Indeed, PKC inhibitors have been shown to prevent the development of pathological receptor expression in the vascular wall and decrease the extent of stroke injury following middle cerebral artery occlusion and subarachnoidal hemorrhage in the rat [12,13]. This evidence concerns the gene PRRT2 and stroke disorder.